Official Statements Archives

February 6, 2023

CLL Society’s Official Statement Regarding Workplace Accommodations for People with CLL/SLL While There is Risk of COVID-19 Exposure (Update 2/6/2023)

As the risk of COVID-19 exposure stretches on, we have updated our official statement concerning working conditions for people with CLL/SLL (Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma) that you can download for your own reference and to share with the appropriate people in your life including HR and co-workers.

September 20, 2022

New Mechanism for Small Medical Practices to Order One or Two Doses of Evusheld

There is a new option for easy access for those with CLL/SLL who are seeking Evusheld. Regardless of their specialty, your healthcare provider can order it directly for only one or two patients.

April 8, 2022

CLL Society’s Official Statement on Evusheld, Boosters, and COVID-19 Therapies

CLL Society is encouraging all chronic lymphocytic leukemia patients who received the Moderna or Pfizer vaccines to promptly arrange for a booster unless otherwise directed by their healthcare team.

February 17, 2022

AstraZeneca to Supply the US Government with an Additional One Million Doses of EVUSHELD Long-Acting Antibody Combination for the Prevention of COVID-19

EVUSHELD is in short supply. And to put it politely, distribution has been inequitable.

July 21, 2021

CLL Society’s Recommendations for COVID-19 Vaccinated Chronic Lymphocytic Leukemia (CLL) Patients-Based Upon the CDC’s Updated Considerations for People Who Are Immunocompromised and Other Underlying Data

Explaining to Family and Friends Why the CDC Guidelines for Those Vaccinated Against COVID-19 Do Not Apply to Chronic Lymphocytic Leukemia Patients

April 6, 2021

Explaining to Family and Friends Why the General CDC Guidelines for Those Vaccinated Against COVID-19 Do Not Apply to Chronic Lymphocytic Leukemia Patients

Explaining to Family and Friends Why the CDC Guidelines for Those Vaccinated Against COVID-19 Do Not Apply to Chronic Lymphocytic Leukemia Patients

March 11, 2021

Interim Public Health Recommendations for People Fully Vaccinated Against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

Interim Public Health Recommendations for People Fully Vaccinate against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

January 4, 2021

CLL Society’s Official Statement Concerning SARS-CoV-2 Vaccine in CLL Patients

Updated: 3/26/2021 We have heard your questions! Should I get the vaccine? Is it safe? Which vaccine? What are the side effects? Can I get COVID from the shots? Where should CLL patients be in line to be vaccinated? CLL Society provides the current best answers to these and

November 6, 2020

CLL Society’s Official Statement Concerning Prioritizing CLL (Chronic Lymphocytic Leukemia) Patients When Triaging Care During the COVID-19 Pandemic

Take it with you! CLL Society’s Official COVID-19 Triage Statement CLL Society has authored an Official Statement to help you help your healthcare providers understand CLL patients’ unique vulnerabilities to COVID-19 and our higher risks of serious complications. This letter to your healthcare provider may help you be attended to faster,

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Official Statements

CLL Society’s Official Statement Regarding Workplace Accommodations for People with CLL/SLL While There is Risk of COVID-19 Exposure (Update 2/6/2023)

New Mechanism for Small Medical Practices to Order One or Two Doses of Evusheld

CLL Society’s Official Statement on Evusheld, Boosters, and COVID-19 Therapies

AstraZeneca to Supply the US Government with an Additional One Million Doses of EVUSHELD Long-Acting Antibody Combination for the Prevention of COVID-19

CLL Society’s Recommendations for COVID-19 Vaccinated Chronic Lymphocytic Leukemia (CLL) Patients-Based Upon the CDC’s Updated Considerations for People Who Are Immunocompromised and Other Underlying Data

Explaining to Family and Friends Why the General CDC Guidelines for Those Vaccinated Against COVID-19 Do Not Apply to Chronic Lymphocytic Leukemia Patients

Interim Public Health Recommendations for People Fully Vaccinated Against COVID-19: What They Mean for the Chronic Lymphocytic Leukemia (CLL) Population

CLL Society’s Official Statement Concerning SARS-CoV-2 Vaccine in CLL Patients

CLL Society’s Official Statement Concerning Prioritizing CLL (Chronic Lymphocytic Leukemia) Patients When Triaging Care During the COVID-19 Pandemic

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT